All News

Although the rate of coronary artery lesions decreased across both cohorts of this trial of children with Kawasaki disease, there were no differences in lesion reduction between those receiving intravenous immunoglobulin (IVIG) alone and those receiving IVIG with aspirin.

The data showed improvements in overall response rates, progression-free survival, and duration of response.

A recent analysis from NCPA showed potential weekly cash flow shortfalls for pharmacies and annual revenue losses.

Medically integrated pharmacies improve collaboration, patient care, communication, and therapy management.

With a more direct mechanism of action against viral replication compared with standard treatments, the small interfering RNA (siRNA)-based MIR 19 treatment could revolutionize outpatient COVID-19 treatment.

At 28 to 179 days, COVID-19 infection in patients with preexisting chronic kidney disease (CKD) was associated with an increased risk of composite kidney events.

Iman Ahmed, PharmD, BCOP, shared key insights about how social determinants of health impact treatment access and outcomes for patients with leukemia.

In mouse models, researchers identified that immune cells within the intestine may prevent unwarranted attacks against harmless food allergens.

Pharmacy and physician were defendants.

Pharmacy technicians have a pivotal opportunity to advance professionally by proactively demonstrating leadership, offering solutions, and clearly communicating their value to health care leaders.

Zahra Mahmoudjafari, PharmD, BCOP, FHOPA, shared insight from the HOPA Annual Meeting 2025.

The safety profile of diazepam nasal spray among pediatric patients was consistent with older patients, supporting its use in this age group.

Arefa Bacchus, PharmD, shared key insights about the use of POMP therapy in patients with acute lymphoblastic leukemia (ALL).

A palliative care pharmacist highlights a spectrum of clinical opportunities for patients, caregivers, and clinicians when rounding at the bedside.

Monica Sawiris, PharmD, said there were noticeable differences in toxicities between each regimen.

The designation was supported based on data from the randomized, double-blind, active-controlled phase 3 interchangeability study.

Patients who received a pneumococcal 13-valent conjugate vaccination had slightly lower incidence of severe COVID-19 outcomes, but the directions of these associations were mixed.

Erin Lexner, PharmD, BCPS, discussed her team’s experience transitioning to outpatient BEAM from inpatient CBV.

Shelby Quinn, PharmD, BCOP shares insights about treatment using osimertinib in early lines.

SOC emphasizes adaptability and individual professional judgment without compromising quality, as individuals are held to the standard and expertise of their practice area.

Strategies for rescuing PTPRD function in diseased livers could provide potential therapeutic options, according to the study authors.

Data indicate potential benefits and risks with nutritional supplement use, highlighting the need for pharmacist counseling.

The high acceptance rates of these interventions demonstrate the key role in optimizing patient care that clinical oncology pharmacists with access to medical records play.

Current treatment strategies are aimed at reducing hematocrit and symptom burden through phlebotomy, aspirin, and cytoreductive agents, while emerging therapies offer promise for better disease control and quality of life.

Imlunestrant is an investigational, brain-penetrating, oral selective degrader of estrogen receptor.

The new indication expands administration methods for the combination of efgartigimod alfa and hyaluronidase-qvfc, which are already approved for the treatment of some immune-related conditions.

Promoting weight management prior to pregnancy and in early life may yield stronger cardiovascular and maternal health.